Effects of Lupeol on Intestinal Anastomosis After Experimental Intestinal Ischemia-Reperfusion Injury in Rats
Drug Design Development and Therapy,
Journal Year:
2025,
Volume and Issue:
Volume 19, P. 479 - 490
Published: Jan. 1, 2025
Intestinal
ischemia/reperfusion
(I/R)
injury
can
occur
in
a
wide
variety
of
diseases
and
surgeries.
If
necessary,
the
blood
flow
should
be
restored,
including
re-anastomosis
by
removing
intestines
with
impaired
circulation.
In
this
process,
anastomotic
strength
is
as
important
inflammatory
responses
oxidative
stress.
Therefore,
we
conducted
study
to
investigate
effects
lupeol
on
intestinal
ischemia-reperfusion
injury,
not
only
biochemically
histopathologically
but
also
miRNAs.
Female
rats
were
randomly
divided
into
six
groups.
While
laparotomy
was
performed
control
group
(Group
C),
anastomosis
sham
S).
other
groups,
superior
mesenteric
artery
clamped
for
45
minutes.
groups
I/R1
L1,
intestine
transected,
end-to-end
at
1st
hour
reperfusion.
I/R24
L24,
procedure
24th
addition,
treatment
given
before
reperfusion
following
4
days
L1
L24.
All
rats,
except
group,
bursting
pressure
measured
5th
day
anastomosis,
then
all
sacrificed.
TNF-α,
IL-6
levels
samples
MDA,
GSH,
caspase-3,
miR-29b-3p,
miR-34a-5p,
miR-495-3p
tissues
measured,
histopathology
examined.
Lupeol
treatment,
which
statistically
significant
some
parameters,
demonstrated
positive
decreasing
TNF,
IL-6,
histopathological
damage
increasing
GSH
pressure.
decreased
miR-34a-5p
expression
increased
miR-29b-3p
expression.
protected
from
I/R
its
antioxidant
anti-inflammatory
effects.
Besides,
it
reduced
strength.
Additionally,
expressions
altered
lupeol.
Language: Английский
<i>Guiera</i> <i>senegalensis</i> Alleviates Ischemia Renal Reperfusion Injury in Albinos Wistar Rats
Mama Sy,
No information about this author
Fatoumata Bah,
No information about this author
Mouhamed Chérif Dial
No information about this author
et al.
Open Journal of Pathology,
Journal Year:
2025,
Volume and Issue:
15(01), P. 16 - 27
Published: Jan. 1, 2025
Therapeutic effect of umbilical cord mesenchymal stem cells on renal ischemia-reperfusion injury
Acta Pharmaceutica,
Journal Year:
2025,
Volume and Issue:
75(1), P. 103 - 118
Published: March 1, 2025
Abstract
Acute
kidney
injury
(AKI)
is
a
growing
global
health
issue
with
no
effective
treatments.
This
study
evaluates
the
therapeutic
effects
of
umbilical
cord
mesenchymal
stem
cells
(UC-MSCs)
on
AKI
caused
by
ischemia-reperfusion
(IRI)
in
mice.
Thirty
mice
were
divided
into
sham
group,
an
IRI
and
MSC-treated
group.
Renal
function
was
assessed,
histological
analysis,
immunofluorescence,
real-time
PCR
used
to
evaluate
renal
damage,
inflammatory
cell
presence,
cytokine
expression
(TNF-α,
IL-6,
IL-10).
Results
showed
that
MSC
treatment
reduced
decreased
pro-inflammatory
cytokines
IL-6),
increased
anti-inflammatory
IL-10,
promoted
repair
homing
sites.
Thus,
MSCs
may
mitigate
reducing
inflammation
enhancing
repair.
Language: Английский